¡@¡@ªñ¦~¨Ó¡AÂå¾Ç¬É¤w¸gÁA¸Ñ¿ò¶Ç©Ê¹L±Ó¯f°ò¥»¤W¤D¬O¤@ºØ»P¦h«°ò¦]¿ò¶Ç¦³ÃöªººC©Ê¹L±Ó©Êµoª¢¤ÏÀ³¡C¦¹ª¢¯g¤ÏÀ³·|¦]¨ü¨ì¦UºØ»¤µo¦]¯Àªº¿Eµo³y¦¨Á{§É¤Wªº¹L±Óµo§@¡A¦Ó¨äµo§@ªº³¡¦ì«h»P¨ä©Ò¿ò¶Ç¨ìªº¦U§O¾¹©x²§±`¦³±K¤ÁªºÃö«Y¡C·í¦¹ª¢¯g¤ÏÀ³µo¥Í©ó¤ä®ðºÞ®É¡A§Ú̺٤§¬°®ð³Ý¯f¡Fµo¥Í©ó»óµÄ¡B²´µ²½¤®É¡AºÙ¤§¬°¹L±Ó©Ê»óª¢¡B¹L±Ó©Êµ²½¤ª¢¡Fµo¥Í©óG¸z¹D®É¡AºÙ¤§¬°¹L±Ó©ÊG¸zª¢¡F¦Ó·í¨äµo¥Í©ó¥Ö½§®É¡A§Ú̺٤§¬°²§¦ì©Ê¥Ö½§ª¢¡C
¡@¡@¦b©Ò¦³¿ò¶Ç©Ê¹L±Ó¯f·í¤¤¡A¥H´¿³y¦¨¦h¦ìª¾¦W¤H¤h¦º¤`¤Î¨äµo§@®É¦³Àb¤HÁ{§ÉÄY««×ªº®ð³Ý¯f¡A³Ì¨ü¤H«µø¡C®ð³Ý¯fªø¤[¥H¨Ó§Y¬°¦U°ê©Ò«µøªº°ê¥Á°·±d°ÝÃD¡A¬°¤H̵Lªk¤u§@©Î´N¾Ç¨àµ£¯Ê½Òªº±`¨£ì¦]¡C¨ä¿©¯f²v»P¦º¤`²v¦b¥þ²y¤j¦h¼Æªº¦a°Ï¥ç¦³³v¦~¼W¥[ªº¶É¦V¡A¥x¤jÂå°|¤p¨à¬ì¬GÁ¶Q¶¯±Ð±Â´¿¦b¥L©Ò¥D¾É½Õ¬dªº¤j¥x¥_¦a°Ï¾Çµ£®ð³Ý¯f¿©¯f²v³ø§i¤¤µo²{¡A®ð³Ý¿©¯f²v¤w¥Ñ¥Á°ê63¦~ªº¦Ê¤À¤§¤@ÂI¤T¡A¼W¥[¦Ü¥Á°ê73¦~ªº¦Ê¤À¤§¤QÂI¤C¤E¡AÅã¥Ü¦³©úÅã¼W¥[ªº²{¶H¡Cªñ¦~¨Ó¡A¥t¥~¨â¦¸ªº¤j¥x¥_¦a°Ï¾Çµ£®ð³Ý¯f¿©¯f²vªº°Ý¨÷½Õ¬d(¥Á°ê87»P91¦~)
¡A¨äµ²ªG§ó¬O§Ö³t¼W¥[¨ì¦Ê¤À¤§¤Q¤»»P¦Ê¤À¤Q¤E¡C¦Ó®ð³Ý¯fªº¦º¤`²v¡A¦b¥Á°ê91¦~¥H«e¤@ª½³£¬O¥xÆW¦a°Ï¨C¦~¤Q¤j¦º¤`ì¦]¤§¤@¡A¨ì¤F¥Á°ê91¦~¤~°¬°²Ä¤Q¤@¦ì¡C¥Ø«e¨C¦~¤´¬ù¦³¤@¤d¤»¦Ê¦ì®ð³Ý¯f¤H¦]®ð³Ýµo§@¦Ó¦º¤`¡C
¡@¡@³q±`§ÚÌ¥i±N»¤µo¹L±Ó©ÊÅé½èµo§@ªº¦]¯À¤À¬°¨â¤jÃþ¡A²Ä¤@Ãþ¦]¯À¬°©I§l¹D¯f¬r·P¬V¡B¹L±Óì(¤×¨ä¬O©~®aÀô¹Ò¤¤ªº¹Ð?»P¿ßª¯µ¥¦³¤òÃdª«)¡B©M¤Æ¾Ç¨ë¿Eª«(¤×¨ä¬O»·Ï©Ò§tªº¥§¥j¤B)
¡A¥iª½±µ»¤µo¹L±Ó©ÊÅé½èµo§@¡F¦Ó²Ä¤GÃþ¦]¯À¦p«ùÄò¼@¯P¹B°Ê¡B¹¥Î¦B§N¹«~¡B¤Ñ®ðÀã«×·Å«×ªº¿E¯PÅܤÆ(¨Ò¦p©u¸`¶i¤J°®§Nªº¬î¤Ñ©Î¬O¤È«á¹p°}«B)¡B¶i¥X§N®ð©Ð¨ä«Ç¤º¥~·Å®t¤j©óÄá¤ó7oC¡B©Mºë¯«±¡ºüªº¤£Ã©w(¦pª±±o¤Ó¿³¾Ä©Î¬O®Á½|¤ß±¡«ÜÆ{´e)µ¥¡A«h¥u·|¹ï¦¤w¦s¦b¹L±Ó©Êµoª¢¥B¤w°ª¹L±Ó«×ªº¼Ð¦a¾¹©x¦p¤ä®ðºÞµ¥¡A³y¦¨¨ä¼È®É©Êªº¦¬ÁY¤ÏÀ³¡C¥un¯f¤HªººC©Ê¹L±Ó©Êµoª¢¤ÏÀ³¸g¹L¹L±Ó§K¬Ì¾Ç±M¬ìÂå®vªº¾A·í³B¸mÀò±o§ïµ½«á¡A¯f¤H§Y¥i¤£¦A¨ü¨ä¼vÅT¡F¤]´N¬O»¡¡A¹L±Ó¯f¤Héw¥H«á¡A§Y¨Ï°Ñ¥[¶ø¹B·|°¨©ÔªQÁɶ]©Î¬O¹¥Î¦B²N²O³£¤£·|¦A»¤µo¹L±Óµo§@¡C
¡@¡@¦b¥xÆW¡A¤Þ°_¨àµ£¹L±Ó¯f±`¨£ªº§l¤J©Ê¹L±Ó즳®a¹Ð¡B¹Ð?¡Bª¯¥Ö®h¡BÁ½¸¡B¿ß¥Ö®h¡BÅðµß¡B¦Ð¤ò¡B©Mªá¯»µ¥¡C±`¨£ªº¹ª«©Ê¹L±Óì«h¥]¬A¤û¥¤¡B³J¥Õ¡B÷«³½¡B°F´ß®üÂA¡B½¼¤l¡B©M¿ÀÃɵ¥¡C¦b¤j³¡¤À·Å·x¼éÀ㪺¦a°Ï¡A®a¹Ð?¬O®a¤¤³Ì¥Dnªº¹L±Óì¡C¥¦·|¾ÉP¦hºØ¹L±Ó©Ê¯e¯f¡A¨Ò¦p¹L±Ó©Ê»óª¢¡B®ð³Ý¤Î²§¦ì©Ê¥Ö½§ª¢µ¥¡C®Ú¾Ú§Ú̪º¸gÅç¡A¦b¥xÆW»¤µo¤p¨à¹L±ÓÅé½èµo§@ªº³Ì«n¹L±Ó줴¥H¹Ð?³Ì¦h¡A¬ù¦û¦Ê¤À¤§¤E¤Q¥H¤W¡CÀô«O¸p´¿©e°U¥xÆW¤j¾Ç©øÂΨt®}º¸¯P±Ð±Â¶i¦æ?¬Û½Õ¬d¡Aµ²ªGµo²{¥xÆW¦a°Ï¦Ê¤À¤§¤C¤Q¤ªº¦í®a¤¤¥R¥¸µÛ¹Ð?¡A«Ç¤º¨C¤½§J¦Ç¹Ð¤¤ÁôÂõۥ§¡¨â¤d°¦¬Æ¦Ü¦³ªº°ª¹F¤@¸U°¦¥H¤Wªº¹Ð?¡A»·°ª©ó»¤µo¹L±Ó®ð³Ý©Ò»Ýnªº¨C¤½§J¦Ç¹Ð¤@¦Ê¦Ü¤@¤d°¦¥H¤W¹Ð?ªº¿@«×¡C¦Ó¥xÆW¦a°Ï©~®a«Ç¤ºÁ`?¼Æ¤À¥¬¥H¦a´à³Ì¦h¡A¨ä¦¸¬°´Ö³Q¡B§É¹Ô¡BªEÀY¡B¦aªO¡B¤Î¨Fµo¡C¦Ó¦b¥xÆW¦a°Ïªº¤£¦P©~®a¹Ð?ºØÃþ¤¤¡A¥H«Î¹Ð?¡]Dermatophagoides
pteronyssinus¡FDP¡^ªº¼Æ¶q³Ì¦h¡A¬ù¥e55%¨ì75%¡A¯»¹Ð?¡]Dermatophagoides farinae¡FDF¡^¦¸¤§¡A¦Ó³o¨âºØ¹Ð?³q±`·|¤Þ°_®ð³Ý¡B¹L±Ó©Ê»óª¢¡B¹L±Ó©Êµ²½¤ª¢¡BëC³Â¯l»P²§¦ì©Ê¥Ö½§ª¢¡C®Ú¾Ú¥x¥_°¨°º¬ö©ÀÂå°|°w¹ï3687¦ì®ð³Ý¯fµ£©Ò¶i¦æªº¥xÆW¦a°Ï¤KºØ±`¨£¹L±Óì(«Î¹Ð?¡B¯»¹Ð?¡Bª¯¥Ö®h¡B¿ß¥Ö®h¡B¼w°êÁ½¸¡B³J¥Õ¡B¤û¥¤¡B©M÷«³½)
ªº¯S²§©ÊIgE§ÜÅé¬ã¨sÅã¥Ü¡A¦b¤Q¤G·³¥H«e¡A¨k©Ê®ð³Ý¯fµ£¤ñ¤k©Ê®ð³Ý¯fµ£¬°¦h¡A¦ý¬O¤j©ó¤Q¤G·³¥H¤W¡A«h¤k©Ê®ð³Ý¯fµ£¤ñ¨k©Ê®ð³Ý¯fµ£¬°¦h¡A¥B¦b¥xÆW¦a°Ï®ð³Ý¯f¨à¹ï³o¨âºØ¹Ð?¹L±Ó¯S²§©ÊIgE§ÜÅé¶§©Ê²vÀH¯fµ£¦~ÄÖªº¼W¥[¦Ó¼W¥[¡A¥Ñ¨â·³¯fµ£ªºDP35.80%¡ADF32.84%¡F¤T·³¯fµ£ªºDP44.72%¡ADF42.41%¡F¤»·³¯fµ£ªºDP63.02%¡ADF58.60%¡F¼W¥[¨ì¤Q¤G·³¥H¤W¯fµ£ªºDP81.36%¡ADF79.66%¡C©Ò¥H¤F¸Ñ¹Ð?ªº¥ÍºA¶i¦Ó°§C®a¤¤¹Ð?¹L±Ó쪺¿@«×¬O¨è¤£®e½wªº¨Æ¡C
¡@¡@Á×§K¹L±Óì¡A§ïµ½©~®aÀô¹Ò(¤×¨ä¬O¹Ð?ªº¨¾ªv) ¡A¦b®ð³Ý±M¬ìÂå®vªº«ü¾É¤U¾A·í¨Ï¥Î¼QÃú§l¤J«¬Ãþ©T¾J(¦³®É©|¶·¥[¤Wªø®Ä«¬¤A¤G«¬¥æ·P¯«¸g¿³¾Ä¾¯¡B¥Õ¤T²m½Õ¸`¯À¡B½wÄÀ«¬¯ùÆP¡B¬Æ¦Ü¤fªAÃþ©T¾J)¡A°t¦X¥²n®É¤A¤G«¬¥æ·P¯«¸g¿³¾Ä¾¯ªº¨Ï¥Î¡A¬°¥Ø«e®ð³Ý¯fµ£ªº³Ì¨Î³B¸m¤è¦¡¡C·í¤@¦ì¹ï¹Ð?¦³¤¤µ¥µ{«×¥H¤W¹L±Óªº¯fµ£¡A¦b¸g¹L®ð³Ý±M¬ìÂå®vªº¾A·í±Ð¾É©M³B¸m¡A¾¨¶q¦aÁ×§K»P¹Ð?ªº±µÄ²¡A¨Ã¥B¾A·í¦a¨Ï¥Î§Ü¹L±Ó©Êµoª¢ÃĪ«(¤×¨ä¬O§l¤J©ÊÃþ©T¾J)¨ÓªvÀø¨äªø´Á²Ö¿n¥B¦¤w¦s¦bªº¹L±Ó©Êª¢¯g¤ÏÀ³¡A«h¤£¦ý¨ä¥Ñ¹Ð?©Ò¤Þ°_ªº¹L±Ó©ÊÁ{§É¯gª¬±o¥HÀò±o½w¸Ñ¡A¥B¯fµ£¹ï¨ä¥¦¦³¶§©Ê¤ÏÀ³¹L±Ó쪺±Ó·P«×¥ç¥iÀò±oÅãµÛ¦a°§C¡C
¡@¡@®a¹Ð?ÄÝ©ó¸`ªÏ°Êª«¡A¨ã¦³¹X¤lª¬ªº¸}¡A«¬ºA¤Î¥Í²z¯S©Ê¬Ò»P©øÂÎÃþ¤£¦P¡C¹Ð?ªº¤ÀÃþ¦a¦ì¬°»jµïºõ¡Bãë?¨Èºõ
( Acarina )¡B?§Î¥Ø(Acariformes)µL®ðªù¨È¥Ø(Astigmata)¡A¹Ð?¬ì (Pyroglyphidae )¡A¤À¥¬©ó¥@¬É¦U¦a¡C¥xÆW¦a°Ï©~®a®a¹Ð¤¤¤§?Ãþ¡A¸g½Õ¬d»PŲ©w«á¡A¦³¤Q¤»ºØ¡A¨ä¤¤¥H«Î¹Ð?¡B¯»¹Ð?¡B·L¨¤¹Ð?¡]Dermatophagoides
microceras¡^¡B±ö¤ó¶ÝÅð?¡]Euroglyphus maynei¡^»P¼ö±aµL¤ö?¡]Blomia tropicalis¡^¬°¥xÆW¦a°Ï±`¨£ªº¹Ð?¹L±Ó¨Ó·½¡C®Ú¾Ú¥x¥_°¨°º¬ö©ÀÂå°|µoªíªº¤åÄm³ø§i²Îp¡A¥xÆW¦a°Ï¹ï¹Ð?¹L±Ó¯fµ£ùØ¡A¹ï©ó¤ºØ¹Ð?¯S²§©ÊIgE§ÜÅé¥X²{²v¥H«Î¹Ð?³Ì°ª¡]87%¡^¡A¨ä¦¸¬°¯»¹Ð?¡]85%¡^¡A·L¨¤¹Ð?¡]84%¡^¡B±ö¤ó¶ÝÅð?¡]77%¡^»P¼ö±aµL¤ö?¡]65%¡^¡C¨ä¤¤¡A®ð³Ý¯fµ£¦å²M¤¤¹ï©ó«Î¹Ð?¡B¯»¹Ð?¡B·L¨¤¹Ð?»P¼ö±aµL¤ö?ªº¯S²§©ÊIgE§ÜÅé¥H¤¤««×¬°¦h¡A¦Ó¹ï©ó±ö¤ó¶ÝÅð?«h¥H»´«×¦û¤j¦h¼Æ¡C§Y¨Ï¯fµ£¥¼¥X²{«Î¹Ð?©Î¯»¹Ð?¥ô¦ó¤@ºØ¯S²§©ÊIgE§ÜÅé¡A¤´¦³6.4%¾÷·|¥X²{¨ä¥L¹Ð?ªº¯S²§©ÊIgE§ÜÅé¡C
¡@¡@®a¹Ð?ªº¥Í©R¶g´Á¦³¤Ó¶¥¬q¡G§Z¡B¥®ÂΡB²Ä¤@Y?¡]protonymph¡^¡B²Ä¤TY?¡]tritonymph¡^¤Î¦¨ÂΡA¦¨ÂΤ§«á¶i¦æ¦³©Ê¥Í´Þ¡C±q§Z¨ì¦¨ÂΪº¾ãÓµo®i¹Lµ{¡A¨ü¨ì¥~¬É·Ã«×¤Î·Å«×ªº¼vÅT«Ü¤j¡C¨Ò¦p«Î¹Ð?³Ì¾A©y¦¨ªøªº·Å«×¬OÄá¤ó¤G¤Q¤«×¡A¤Ó°ª©Î¤Ó§Cªº·Å«×¬Ò·|¨Ï¹Ð?ªº¥Íªø½wºC¡C¦¹¥~®a¤¤¤£¦P¦a¤èªº¹Ð?¡A¦]·Å«×ªº¤£¦P¡A¦¨ªøªº³t«×¤]¤£¦P¡C¨Ò¦p¦b¦B§N¦aªO¤Wªº¦a´à¤¤ªº¹Ð?¡A¨ä¥Íªø³t«×«h¤ñ¨Fµo¤¤ªº¹Ð?ÁÙºC¡C
¡@¡@°£¤F·Å«×¤§¥~¡A·Ã«×¹ï©ó¹Ð?ªº¼vÅT¥ç¬Û·í¤j¡C¹Ð?Å餺ªº¤ô¤À§t¶q¬ù¦ûÅ髪º¦Ê¤À¤§¤C¤Q¦Ü¤C¤Q¤¡A¥¦ÌÂǥѧl¦¬¥~¬ÉªÅ®ð¤¤ªº¤ô»]®ð¨Ó¹F¨ìÅ餺¤ô¤Àªº¥¿Å¡C¹Ð?©Ò»ÝªºÀô¹Ò·Ã«×¡AÀH©P¾Dªº·Å«×¤£¦P¦Ó²§¡C¨Ò¦p¯»¹Ð?¦bÄá¤ó¤G¤Q¦Ü¤G¤Q¤«×ªº±¡§Î¤U¡A¨¬¥Hºû«ùÅ餺¤ô¤Àªº¥¿Åªº³Ì§C©³Àô¹Ò·Ã«×¬O¦Ê¤À¤§¤¤Q¤¡C
¡@¡@¹Ð?ªºÁT«K¡B³è²G¡B«ÍÅé¤Î¥Í´Þ¹Dªº¤Àªcª«¬Ò·|³y¦¨¹L±Ó¤ÏÀ³¡C¥Ø«e¹Ð?P±Óª«½è®Ú¾Ú¤£¦Pªºµ²ºc¦¨¥÷¡B§Ç¦C¤Î¤À¤l¶q¡A¤À¦¨¤F¤Q´XºØ¡C¹Ð?§t¦³ªº¹L±Ó즳¡G(1)¥b¯ÖÓi»Ä¤ô¸Ñ?(cysteine
proteases)²Ä¤@¸s¹L±Óì¡G(D. pteronyssinus¢¹¡AD. farinae¢¹©MD. microceras¢¹)¡A(2)µ·Ói»Ä¤ô¸Ñ?(serine
proteases) (²Ä¤T¸s¹L±Óì)¡A(3)¾ý¯»?(amylase) (²Ä¥|¸s¹L±Óì)¡C³o¨Ç¨ã¹L±Óì¯S©Êªº»Ã¯À¦s¦b©ó¹Ð?ªº±Æªnª«¤¤¡C¨ä¤¤Der
p 1¬O³Ì¥DnªºP±Óª«½è¡A¥¦¬OÄÝ©ó¥b¯ÖÓi»Ä³J¥Õ?¡A·½¦Û©ó¹Ð?®ø¤Æ¹Dªº¤W¥Ö²ÓM¡A¥Dn¬O¥Î¨Ó®ø¤Æ¹ª«¡C²Ä¤G¸s¹L±Óì«h¥Dn¨Ó¦Û¹Ð?ªºÂßÅé¦Ó«D±Æªnª«(D.
pteronyssinus II¡AD. farinae II)¡C®a¹Ð¤¤¥Dnªº¹L±Ó쬰²Ä¤@¸s©M²Ä¤T¸s¡C ¹Ð?¾ÉP¹L±Ó¤ÏÀ³¥i¯à¤§¾÷Âà¦p¤U¡G
1. »¤µo²Ä¤G«¬T²ÓM´C¤¶§K¬Ì¤ÏÀ³¡]Th2-mediated immune response¡^¡G
Der p 1·|¥[±j¶Ý¥ì¬õ©Ê¥Õ¦å²y¡]eosinophil¡^©MªÎD²ÓM¡]mast cell¡^ªº§@¥Î¡A¦ÓÄÀ©ñ¥X¤j¶qªº«eµoª¢¤¶½è¡]pro-inflammatory
mediator¡^¡A¦Ó¾ÉP¤Fµoª¢¤ÏÀ³¡C
Der p 1¥ç·|¼vÅTT²ÓM°¾¦V¡A¨Ï¨ä¤Àªc¸û¦h²Ä¤G«¬T²ÓM´C¤¶§K¬Ì¤ÏÀ³ªº²ÓM¿E¯À¡]type 2 cytokine¡^¡C
2. ¯}ÃaCD23¡G
CD23¬OB²ÓM¤Wªº§K¬Ì²y³J¥ÕE¡]IgE¡^±µ¨üÅé¡A·í§K¬Ì²y³J¥ÕEµ²¦X¨ìCD23®É¡A·|²£¥Ít¦^õX¦Ó§í¨î§K¬Ì²y³J¥ÕEªº¦X¦¨¡C¦ýYCD23¾D¨ì¥b¯ÖÓi»Ä³J¥Õ?µõ¸Ñ¡]cleavage¡^¡A«h§K¬Ì²y³J¥ÕEªº¦X¦¨±NµLªk¨ü¨ì§í¨î¡C
3. µõ¸ÑT²O¤Ú²y¤W¤¶¥Õ½è-2±µ¨üÅé¡]IL-2 receptor¡FCD25¡^¡G
Der p 1µõ¸Ñ¤FT²O¤Ú²y¤W¤¶¥Õ½è-2±µ¨üÅé¡A¦]¦Ó´î¤Ö¤FT²O¤Ú²yªº¼W¥Í¤Î¤þ«¬¤zÂZ¯À¡]interferon-£^¡^ªº²£¥Í¡A¦Ó°¾¦V¤F²Ä¤G«¬T²ÓM´C¤¶§K¬Ì¤ÏÀ³¡C
4. ¯}Ãa©I§l¹D¤W¥Ö¡G
¥b¯ÖÓi»Ä³J¥Õ?·|ª½±µ¯}Ãa©I§l¹D¤W¥Ö¡A³y¦¨³q³z©Ê¼W¥[¡A¨Ï¹L±Óì§ó®e©ö³q¹L¤W¥Ö²Õ´¡C
5. §í¨î£\1-antitrypsin¡G
£\1-antitrypsin¬O¦b©I§l¹D¤¤¥Dnªº§Ü³J¥Õ?¡]antiprotease¡^¡A¥¦·|§í¨î©I§l¹D¤¤³J¥Õ?ªº§@¥Î¡]¨Ò¦p²Óµß³J¥Õ?¡^¡A¨¾¤î²ÓM³Q¯}Ãa¡CµM¦ÓDer
p 1·|§í¨î£\1-antitrypsinªº¬¡©Ê¡A¾ÉP©I§l¹D¤W¥Ö²Õ´ªº¶Ë®`¡C
®a¤¤¹Ð?¨¾ªvªº°¨°º¸gÅç¤Àz¦p¤U¡G
1. °§C«Ç¤º·Ã«×¡G
«O«ù«Ç¤º·Ã«×¦b¦Ê¤À¤§¤¤Q¥H¤U¡A¬O°§C¹Ð?¤Î¨äP±Óª«³Ì«nªº¤èªk¡C¥i¨Ï¥Î°ª®Ä¯à°£Àã¾÷©Î§N®ð¾÷¨Ó°§C«Ç¤º·Ã«×¡C
2. ²¾°£¦a´à¡B«pµ¡Ã®¥¬¡B§¤¹Ô¤Î¼u®§É¡G
¦]¦a´à¡B«pµ¡Ã®¥¬¡B§¤¹Ô¤Î¼u®§É®e©ö»W¿n¥Ö®h©M«O¯d¤ô¤À¡A¬O¹Ð?¥Íªøªº·Å§É¡C©Ò¥H«ØÄ³§â¦a´à¤Î¼u®§É²¾°£¡A«pµ¡Ã®¥¬§ï¦¨¸ûÁ¡ªº§÷½è©Î¦Ê¸µ¡¡A¨Fµo©Î´È¹Ôªºªí±¥Î¥Ö²§÷½è©Î¥H¤ì»s®a¨ã¨ú¥N¡C¹ï¹Ð?¨ã¦³ÄY«¹L±Óªº¯fµ£®a®x¡A³Ì¦n¶·¥þ®aºÎ¤ìªO§É©Î¦aªO¤W¹Ô¥HÃý«ß¾Þ¥Îªº¶ì½¦«÷¹Ô¡F¥þ®a©Ò¦³ªº©Ð¶¡¶·²¾°£¼u®§É¹Ô¡B·¦µ·¹Ô¡B¤Î®üºø¹Ô¡A¤£¥i¨Ï¥Î¯ó»V¡Bºfºf¦Ì¡B¯D¤y³Q¡B¤ò´à¡B©Î«p«ªººø³Q¡A§_«h¶·¥H¸g¬ü°ê¹«~ÃĪ«ºÞ²z§½»{ÃÒªº¨¾?®M®M¤§¡C
3. µLªk²¾°£¼u®§É®É¡A¶·¨Ï¥Î¸g¬ü°ê¹«~ÃĪ«ºÞ²z§½»{ÃÒªº¨¾?®M®M¤§¡G
®Ú¾Ú§Ú̪º¬ã¨s²Îp¡A²¾°£¼u®§É¤»¶g«á¡A¥§¡¹Ð?¿@«×¤U°61%(Der p 1, ELISA)¡A¦y®p¦R®ð¬y³t¡]PEFR¡^¥§¡¤W¤É49¤É/¤À¡]l/min¡^¡A®ð³ÝÁ{§É¯gª¬¤À¼Æ¥§¡¶i¨B4.2¤À¡C¦Ó¨Ï¥Î¬ü°ê¹«~ÃĪ«ºÞ²z§½»{ÃÒªº¨¾?®MªÌ¡A«h¥§¡¹Ð?¿@«×¤U°62.4%¡A¦y®p¦R®ð¬y³t¥§¡¤W¤É68¤É/¤À¡A®ð³ÝÁ{§É¯gª¬¤À¼Æ¥§¡¶i¨B3.15¤À¡C¨âºØ±¡ªp»P¥¼²¾°£¼u®§É¤]¥¼¨Ï¥Î¨¾?®MªÌ¤ñ¸û¡A²Îp¤W¬Ò§e²{¦³·N¸qªº§ïµ½¡C
4. ¹ì¨ãªº¬~º°¡G
¦Ü¤Ö¤@Ó¬P´Á¥ÎÄá¤ó¤¤Q¤«×¥H¤Wªº¼ö¤ô©Î¯M°®¾÷¥ý³B²z¹ì¨ã¡]ªEÀY®M¡B³Q¤l¡B§É³æ¡^¤Q¤ÀÄÁ¡A¦A¥H²M¤ô¬~º°°®²b¡A¨âÓ¨BÆJ¯Ê¤@¤£¥i¡C¦]¬°¯M°®©Î°®¬~¥u¯à±þ¦º¹Ð?¡A«oµLªk¯}Ãa©Ò¦³ªºP±Óª«½è¡C¦ÓY³æ³æ¥u¦³¤ô¬~¡A«h¥i¥h°£P±Óª«½è¡]¦]¨ä¬°¤ô·»©Ê¡^¡A¦ý«oµLªk¨Ï¹Ð?¦º¤`¡C©Ò¥H¨Ï¥Îªº¹ì¨ã§÷½è¥²¶·¥i@¼ö¤ô²M¬~ªº¡C
5. ¥H¦³°ª®Ä¯à²É¤lªÅ®ð¹LÂo¡]high-efficiency particulate
air filter¡FHEPA¡^¨t²Îªº §l¹Ð¾¹§l¦a´à¡G
Y¤£Ä@·N©ÎµLªk²¾°£¦a´àªº¸Ü¡A«h¦Ü¤Ö¤@¬P´Á¥HHEPA§l¹Ð¾¹§l¦a´à¤@¦¸¡A¥Bn¶Ô©ó§ó´«§l¹Ð¾¹³U¤l¡C§l¹Ð¾¹³U¤ln¦³¨â¼h¡A¥H¨¾¤îP±Óª«¦b§l¹Ðªº¹Lµ{¤¤¨T¤Æ¡C¤£¹L§Y¨Ï¦p¦¹¡A§l¹Ð¾¹ÁÙ¬O¥u¯à²¾°£ªí±ªº¹Ð?¤Î¨äP±Óª«¡A¸û²`¼hªº«h¨S¦³¿ìªk¡C
6. ¦Bá¹Ð?¡G
¨CÓ§«ô§â¶ñ¥Rª±¨ã¡B¤pª±°¸¡B¤pªEÀY©Î¦çªA©ñ¤J§Ná®w¤¤¡Aºû«ùÄá¤ó¹s¤U¤Q¤C¦Ü¹s¤U¤G¤Q«×¤G¤Q¥|¤p®É¥H¤W¡A¥i¥H¦³®Äªº±þ¦º¹Ð?¡C¤§«áÁٻݥH²M¤ô¬~º°¡A¥H¥h°£¹Ð?«ÍÅé¤ÎP±Óª«¡C
7. ªÅ®ðÂo²b¡G
¦í®aªÅ®ðÂo²b¾¹¡]¥]¬AHEPA¡^¬O±`¥Îªº¾÷±ñ¹LÂo¾¹¡A¨ä¦b©~®a¹Ð?¨¾ªvªº¨¤¦â©|¥¼½T©w¡C
8. ²M²zªÅ½Õ¨t²Î¤ÎÂoºô¡G
¦]¹Ð?«Ü¤Ö»E¿n¦bªÅ½Õ¨t²Î¤¤¡A©Ò¥H¦¹¨BÆJ¬O¤£»Ýnªº¡C¦ý¦¹¨BÆJ¥i¥h°£¦Ç¹Ð¡B¸H®h¤ÎÅðµß¹L±Óì¡C
9. ¯ä®ñ»s³y¾÷¡G¥Ø«e¨S¦³ÃÒ©ú¬O¦³®Äªº¡C
10. ¨Ï¥Î±þ?¤Æ¾Ç»s¾¯¡G
¦³¨Ç¤Æ¾Ç¾¯¡A¦p benzyl benzoate pyrethroids¡BPhenyl salicylate¥i¥H±þ¦º¹Ð?¡F
Natamycin¥i¥HÂǥѱþ¦ºÅðµßÌU¤l(¹Ð?ªº¹ª«)¦Ó´î¤Ö¹Ð?ªº¶q¡FTannic acid¥i¥H§ïÅܹÐ?¹L±Ó쪺µ²ºc¦Ó°§C¨äP±Ó©Ê¡C¼vÅT±þ?¾¯¥\®Äªºì¦]¥]¬A¨Ï¥Î¤èªk¡B¾¯«¬¡B¬I¥ÎªºÀô¹Ò¥H¤Î¨Ï¥Î³o¨ÇÃľ¯«á²¾°£³o¨Ç§Ü쪺¦³®Ä©Ê¡C¨ì¥Ø«e¬°¤îªº¬ã¨s¨Ã¨S¦³±o¨ì¤@Pªºµ²½×¡A¦]¦¹¤£«ØÄ³¨Ï¥Î±þ?¾¯¡C¦³¬ã¨s«ü¥X±N0.03%f¥Ò°òf¥Ò»ÄÆQ¡]benzyl
benzoate¡^©M0.2%ÑÛ¾ð´Óª«ªo¡]eucalyptus oils¡^ˤJ¬~¦ç¾÷¤¤¤]¥i±þ¦º¹Ð?¡A¦ýÑÛ¾ð´Óª«ªoªº¨ý¹D·|¦b¦çªA¤W´Ý¯d2¦Ü3¤Ñ¡C
11. ¦b§@©~®aÀô¹Ò²M¼ä®É¡A¹Ð?¹L±Óªº¯f¤HÀ³¦b²M¼ä®É¤Î²M¼ä«á1¤p®É¤º»·Â÷¸Ó³B¡C
12. ¹ï©ó¹Ð?¦Ó¨¥¡Aª¯¿ßªº¥Ö®h¥i¥H¬O¨ä¹ª«¡A©Ò¥H²¾°£Ãdª«¹L±Óì¹ï©ó¹Ð?¹L±Óªº¤H¤]¦³À°§U¡C
µ²½×
¥xÆW¦a³B¨È¼ö±a¡A²×¦~·Ã«×°ª¡A¥|©u¤£©úÅã¡A¥B¥Í¬¡Àô¹Ò¾ÖÀ½¡A¦]¦¹®a¤¤ªº
¹Ð?¬O¹L±Ó®ð³Ý¯fµ£³Ì«nªº¹L±Óì¡C©Ò¥H¦p¦ó°µ¦n¹Ð?ªº¨¾ªv¤u§@¬O¥xÆW¦a°Ï¨CÓ¦³¹L±Ó¿ò¶ÇÅé½è®a®x³Ì¢¤Á»Ýnªº¤u§@¡C
|